Peter Gmeiner Department of Chemistry and Pharmacy Friedrich-Alexander University Erlangen-Nuernberg Biography Publications Institution JoVE Articles Peter Gmeiner has not added a biography. If you are Peter Gmeiner and would like to personalize this page please email our Author Liaison for assistance. Publications Rational Design of Agonists for Bitter Taste Receptor TAS2R14: from Modeling to Bench and Back Cellular and Molecular Life Sciences : CMLS. Feb, 2020 | Pubmed ID: 31236627 Structure-based Exploration of an Allosteric Binding Pocket in the NTS1 Receptor Using Bitopic NT(8-13) Derivatives and Molecular Dynamics Simulations Journal of Molecular Modeling. Jun, 2019 | Pubmed ID: 31209646 Development of Covalent Antagonists for β1- and β2-adrenergic Receptors Bioorganic & Medicinal Chemistry. Jul, 2019 | Pubmed ID: 31151791 Monitoring of the Dopamine D2 Receptor Agonists Hordenine and N-methyltyramine During the Brewing Process and in Commercial Beer Samples Food Chemistry. Mar, 2019 | Pubmed ID: 30409657 Structure-guided Development of Selective M3 Muscarinic Acetylcholine Receptor Antagonists Proceedings of the National Academy of Sciences of the United States of America. 11, 2018 | Pubmed ID: 30404914 Visualization of Ligand-induced Dopamine D and D Receptor Internalization by TIRF Microscopy Scientific Reports. 09, 2017 | Pubmed ID: 28883522 β-Arrestin Biased Dopamine D2 Receptor Partial Agonists: Synthesis and Pharmacological Evaluation Bioorganic & Medicinal Chemistry. 10, 2017 | Pubmed ID: 28870802 Potent Haloperidol Derivatives Covalently Binding to the Dopamine D2 Receptor Bioorganic & Medicinal Chemistry. 10, 2017 | Pubmed ID: 28666858 Development of Molecular Tools Based on the Dopamine D Receptor Ligand FAUC 329 Showing Inhibiting Effects on Drug and Food Maintained Behavior Bioorganic & Medicinal Chemistry. 07, 2017 | Pubmed ID: 28495386 Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased DR Agonists Journal of Medicinal Chemistry. 06, 2017 | Pubmed ID: 28489379 Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors Pharmaceuticals (Basel, Switzerland). Mar, 2017 | Pubmed ID: 28287433 NTS2-selective Neurotensin Mimetics with Tetrahydrofuran Amino Acids Bioorganic & Medicinal Chemistry. 01, 2017 | Pubmed ID: 27842797 Structure-guided Development of Dual β2 Adrenergic/dopamine D2 Receptor Agonists Bioorganic & Medicinal Chemistry. 06, 2016 | Pubmed ID: 27132867 Arrestin-Bound Rhodopsin: A Molecular Structure and Its Impact on the Development of Biased GPCR Ligands Angewandte Chemie (International Ed. in English). Nov, 2015 | Pubmed ID: 26361376 1,4-Disubstituted Aromatic Piperazines with High 5-HT2A/D2 Selectivity: Quantitative Structure-selectivity Investigations, Docking, Synthesis and Biological Evaluation Bioorganic & Medicinal Chemistry. Sep, 2015 | Pubmed ID: 26299826 Selective GPCR Ligands Bioorganic & Medicinal Chemistry. Jul, 2015 | Pubmed ID: 25818769 Structure-based Evolution of Subtype-selective Neurotensin Receptor Ligands ChemistryOpen. Oct, 2014 | Pubmed ID: 25478316 Synthesis and Binding Profile of Haloperidol-based Bivalent Ligands Targeting Dopamine D(2)-like Receptors Bioorganic & Medicinal Chemistry Letters. Aug, 2014 | Pubmed ID: 25047579 Covalent Agonists for Studying G Protein-coupled Receptor Activation Proceedings of the National Academy of Sciences of the United States of America. Jul, 2014 | Pubmed ID: 25006259 In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-mediated Radiotherapy by Small-animal Positron Emission Tomography: a Pilot Study Pharmaceuticals (Basel, Switzerland). Apr, 2014 | Pubmed ID: 24743103 라벨없는 임피던스 기반 GPCR 분석에서 처리량 증가를위한 단계별 투약 프로토콜 Judith A. Stolwijk1, Anne-Kathrin Mildner1, Christian Kade1, Michael Skiba1, Guenther Bernhardt2, Armin Buschauer2, Harald Huebner3, Peter Gmeiner3, Joachim Wegener1,4 1Institute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, 2Institute of Pharmacy, University of Regensburg, 3Department of Chemistry and Pharmacy, Friedrich-Alexander University Erlangen-Nuernberg, 4Fraunhofer Research Institution for Microsystems and Solid State Technologies EMFT JoVE 60686 Biochemistry
라벨없는 임피던스 기반 GPCR 분석에서 처리량 증가를위한 단계별 투약 프로토콜 Judith A. Stolwijk1, Anne-Kathrin Mildner1, Christian Kade1, Michael Skiba1, Guenther Bernhardt2, Armin Buschauer2, Harald Huebner3, Peter Gmeiner3, Joachim Wegener1,4 1Institute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, 2Institute of Pharmacy, University of Regensburg, 3Department of Chemistry and Pharmacy, Friedrich-Alexander University Erlangen-Nuernberg, 4Fraunhofer Research Institution for Microsystems and Solid State Technologies EMFT JoVE 60686 Biochemistry
